NCT03358355View on ClinicalTrials.gov

Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 7, 2016

Primary Completion Date

August 30, 2017

Study Completion Date

August 30, 2017

Conditions
Peripheral Artery DiseasePADPeripheral Arterial Disease
Interventions
DRUG

unacelyated ghrelin

We will test doses of 10 ug/kg, 20 ug/kg, and 40 ug/kg of unacylated ghrelin on three separate days for each participant.

Trial Locations (1)

60611

Northwestern University Feinberg School of Medicine, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT03358355 - Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial | Biotech Hunter | Biotech Hunter